The efficacy of sequential therapy with docetaxel and cabazitaxel for castration-resistant prostate cancer: A retrospective multi-institutional study in Japan.

Naoki Terada Atsuro SawadaHiroaki KawanishiTakeru FujimotoToshihiro MagaribuchiIchiro ChiharaKohei HashimotoToshihiko SakuraiYosuke ShimizuMasayuki UegakiMasakazu NakashimaShintaro NaritaMasashi KubotaYusuke YamadaYoichiro TohiKoh OkabeJyunji YatsudaToshiyuki Kamoto

Published in: International journal of urology : official journal of the Japanese Urological Association (2022)

For patients for whom DOC was not effective, sequential CBZ might have change to be effective. The PSA levels at the start of DOC and CBZ might be a potential prognostic biomarker.

Keyphrases

end stage renal disease
prostate cancer
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
prognostic factors
stem cells
patient reported outcomes
mesenchymal stem cells
locally advanced
human health
patient reported